Your browser doesn't support javascript.
loading
Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand.
Page, Michael M; Hardikar, Winita; Alex, George; Bates, Sue; Srinivasan, Shubha; Stormon, Michael; Hall, Kat; Evans, Helen M; Johnston, Peter; Chen, John; Wigg, Alan; John, Libby; Ekinci, Elif I; O'Brien, Richard C; Jones, Robert; Watts, Gerald F.
Afiliación
  • Page MM; Medical School, The University of Western Australia, Perth, Australia; Western Diagnostic Pathology, Perth, Australia.
  • Hardikar W; Gastroenterology and Clinical Nutrition, The Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
  • Alex G; Gastroenterology and Clinical Nutrition, The Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
  • Bates S; Gastroenterology and Clinical Nutrition, The Royal Children's Hospital Melbourne, Melbourne, Australia.
  • Srinivasan S; Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Stormon M; Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Gastroenterology and Hepatology, The Children's Hospital at Westmead, Sydney, Australia.
  • Hall K; Hepatobiliary and Liver Transplant Surgery Unit, Austin Health, Melbourne, Australia.
  • Evans HM; Paediatric Gastroenterology and Hepatology, Starship Child Health, Auckland, New Zealand; Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
  • Johnston P; New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand.
  • Chen J; South Australia Liver Transplant Unit, Flinders Medical Centre, Adelaide, Australia; College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Wigg A; South Australia Liver Transplant Unit, Flinders Medical Centre, Adelaide, Australia; College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • John L; South Australia Liver Transplant Unit, Flinders Medical Centre, Adelaide, Australia.
  • Ekinci EI; Department of Endocrinology, Austin Health, Melbourne, Australia; The Australian Centre for Accelerating Diabetes Innovation, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia; Department of Medicine, Austin Health, Melbou
  • O'Brien RC; Department of Endocrinology, Austin Health, Melbourne, Australia; Department of Medicine, Austin Health, Melbourne Medical School, The University of Melbourne, Melbourne, Australia.
  • Jones R; Hepatobiliary and Liver Transplant Surgery Unit, Austin Health, Melbourne, Australia; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia.
  • Watts GF; Medical School, The University of Western Australia, Perth, Australia; Department of Cardiovascular Medicine, Royal Perth Hospital, Perth, Australia. Electronic address: gerald.watts@uwa.edu.au.
Atherosclerosis ; 387: 117305, 2023 12.
Article en En | MEDLINE | ID: mdl-37863699

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Eliminación de Componentes Sanguíneos / Trasplante de Hígado / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Hipercolesterolemia Familiar Homocigótica / Hiperlipoproteinemia Tipo II / Anticolesterolemiantes / Infarto del Miocardio Límite: Child / Child, preschool / Female / Humans País/Región como asunto: Oceania Idioma: En Revista: Atherosclerosis Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Eliminación de Componentes Sanguíneos / Trasplante de Hígado / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Hipercolesterolemia Familiar Homocigótica / Hiperlipoproteinemia Tipo II / Anticolesterolemiantes / Infarto del Miocardio Límite: Child / Child, preschool / Female / Humans País/Región como asunto: Oceania Idioma: En Revista: Atherosclerosis Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Irlanda